The problem with the "tanning agent" approach is that the medical authorities do not consider sunburn or fair skin to be a disease. For a drug to get approval it has to treat a recognised disease. Hence CUV are looking to get the drug approved for sun allergy (a recognised disease). Once the drug is approved then a doctor can prescribe it to treat whatever he wants (including sunburn, skin cancer, fair skin etc).
I think Botox took this route as well - it was approved for a particular disease and then plastic surgeons were able to use it for beauty treatments - unfortunately, wrinkles are not recognised as a disease either.
Spartz.
selling volume falling, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.20 |
Change
-0.200(1.39%) |
Mkt cap ! $710.8M | |||
| Open | High | Low | Value | Volume |
| $14.35 | $14.60 | $13.87 | $1.831M | 129.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 31 | $14.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.20 | 317 | 1 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| CUV (ASX) Chart |